Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis
British Journal of Pharmacology · 2023
DOI: 10.1111/bph.16096 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2023. Verfasst von Changlong An und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Macrophage Activation, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background and Purpose Renal fibrosis is a common feature of chronic kidney disease. Myeloid fibroblasts and macrophages contribute significantly to the pathogenesis of renal fibrosis. However, the molecular mechanisms underlying myeloid fibroblast activation and macrophage polarization are not fully understood. In this study, we examined the role of Jumonji domain‐containing protein‐3 (JMJD3) in myeloid fibroblast activation, macrophage polarization, and renal fibrosis development in a preclinical model of obstructive nephropathy. Experimental Approach To examine the role of JMJD3 in renal fibrosis, we generated mice with global or myeloid cell‐specific deletion of JMJD3, and we treated wild‐type mice with vehicle or GSK‐J4 (selective JMJD3 inhibitor). Mice were subjected to unilateral ureteral obstructive injury to induce renal fibrosis. Key Results JMJD3 expression was significantly increased in the kidneys during the development of renal fibrosis, which was associated with an increase in H3K27 dimethylation. Mice with either global or myeloid JMJD3 deficiency exhibited significantly reduced total collagen deposition and extracellular matrix protein production, myeloid fibroblast activation and M2 macrophage polarization in the obstructed kidney. Moreover, IFN regulatory factor 4, a mediator of M2 macrophage polarization, was significantly induced in the obstructed kidneys, which was abolished by JMJD3 deficiency. Furthermore, pharmacological inhibition of JMJD3 with GSK‐J4 attenuated kidney fibrosis, reduced myeloid fibroblast activation and suppressed M2 macrophage polarization in the obstructed kidney. Conclusion and Implications Our study identifies JMJD3 as a critical regulator of myeloid fibroblast activation, macrophage polarization, and renal fibrosis development. Therefore, JMJD3 may represent a promising therapeutic target for chronic kidney disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
- Department of Immunology, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
- Department of Cell Biology, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
- Institute for Systems Genomics, University of Connecticut, Farmington, Connecticut, USA.
- Renal Section, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA.
ORCID-Profile: Baihai Jiao, Yanlin Wang
Förderung
- BLRD VA
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Veterans Affairs
Zitieren
APA
An, C., Jiao, B., Du, H., Tran, M., Song, B., Wang, P., Zhou, D., & Wang, Y. (2023). Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis. British Journal of Pharmacology. https://doi.org/10.1111/bph.16096
Vancouver
An C, Jiao B, Du H, Tran M, Song B, Wang P, et al. Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis. British Journal of Pharmacology. 2023. doi:10.1111/bph.16096
BibTeX
@article{An2023,
author = {An, Changlong and Jiao, Baihai and Du, Hao and Tran, Melanie and Song, Bo and Wang, Penghua and Zhou, Dong and Wang, Yanlin},
title = {Jumonji domain‐containing protein‐3 (JMJD3) promotes myeloid fibroblast activation and macrophage polarization in kidney fibrosis},
journal = {British Journal of Pharmacology},
year = {2023},
doi = {10.1111/bph.16096}
}
EUVIMED